Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2015, Vol. 35 Issue (10): 66-71    DOI: 10.13523/j.cb.20151010
综述     
乙型脑炎病毒及其疫苗最新研究进展
郭杨1, 林华2
1. 四川省疾病预防控制中心 成都 610041;
2. 四川出入境检验检疫局 成都 610041
The New Development of Japanese Encephalitis Vaccine and Vaccine Research
GUO Yang1, LIN Hua2
1. Sichuan Centre for Disease Control and Prevention, Chengdu 610041, China;
2. Sichuan Entry-exit Inspection and Quarantine Bureau, Chengdu 610041, China
 全文: PDF(988 KB)   HTML
摘要:

流行性乙型脑炎(Japanese encephalitis,JE)简称乙脑,是由乙脑病毒感染,流行在亚洲和太平洋地区重要的病毒脑炎,近年乙脑流行地区在不断扩大。目前尚无特效的治疗流行性乙型脑炎的方法,控制蚊虫传播和免疫接种是当前的主要防御手段。随着对乙脑病毒研究的深入,利用基因工程技术研制新型候选疫苗已成为预防乙脑新的发展方向。简要综述了乙型脑炎病毒的基因组结构及其蛋白功能,以及国内外乙型脑炎疫苗的最新研究进展。

关键词: 乙型脑炎病毒疫苗灭活最新研究进展疫苗减毒    
Abstract:

Japanese encephalitis(JE),caused by Japanese encephalitis virus(JEV)infection,is an important viral encephalitis which is prevalent in Asian and Pacific areas.JE endemic areas expanded in recent years.At present there is no specially effective antiviral treatment for JE.Therefore,vaccination and vector control constitute major measures.Sevaral new promising Japanese encephalitis vaccine candidates have been developed. A review on JEV genomic structure and their function, recent advances in the area of Japanese encephalitis vaccine development was given.

Key words: Japanese encephalitis virus    Vaccines attenuated    Vaccines inactivate    Research progress
收稿日期: 2015-08-07 出版日期: 2015-10-25
ZTFLH:  Q789  
通讯作者: 郭杨     E-mail: 123484596@126.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  

引用本文:

郭杨, 林华. 乙型脑炎病毒及其疫苗最新研究进展[J]. 中国生物工程杂志, 2015, 35(10): 66-71.

GUO Yang, LIN Hua. The New Development of Japanese Encephalitis Vaccine and Vaccine Research. China Biotechnology, 2015, 35(10): 66-71.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20151010        https://manu60.magtech.com.cn/biotech/CN/Y2015/V35/I10/66

[1] Zheng Y,Li M,Wang H, et al.Japanese encephalitis and Japanese encephalitis virus in mainland China,Rev Med Virol,2012,22(5):301-322.
[2] Campbell G L, Hills S L, Fischer M,et al. Estimated global incidence of Japanese encephalitis: a systematic review,Bulletin of the World Health Organization, 2011,89(10):766-774.
[3] Erlanger T E, Weiss S, Keiser J, et al. Past, present, and future of Japanese encephalitis, Emerging Infectious Diseases,2009,15:1-7.
[4] Ghosh D,Basu A.Japanese encephalitis-a pathological and clinical perspective, PLoS Neglected Tropical Diseases,2009,3(9):e437.
[5] 王宇明,施光峰,宁琴,等.感染病学.人民卫生出版社,2010.8:164. Wang Y M, Shi G F, Ning Q,et al.Infection Internationa.Beijing:People's Medical Publishing House, 2010.8:164.
[6] Ghosh D, Basu A. Japanese encephalitis——a pathological and clinical perspective, PLoS Neglected Tropical Diseases,2009,3(9):e437.
[7] van den Hurk A F, Ritchie S A,Mackenzie J S. Ecology and geographical expansion of Japanese encephalitis virus, Annual Review of Entomology,2009,54:17-35.
[8] 谢荣辉,朱函坪,张晓锋,等.浙江省猪血清中乙脑病毒的分离鉴定及抗体的测定.中国人兽共患病学报,2010,26(12):1123-1125. Xie R H, Zhu H P, Zhang X F,et al.Isolation of Japanese encephalitis virus and detection of antibody against Japanese encephalitis virus in serum of swine from Zhejiang, Chinese Journal of Zoonoses,,2010,26(12):1123-1125.
[9] Misra U K, Kalita J. Overview:Japanese encephalitis. Progress in Neurobiology, 2010,91(2):108-200.
[10] Ohrr H,Tandan J B,Sohn Y M,et al.Effect of single dose of SAl4-14-2 vaccine l year after immunization in Nepalese children with Japanese encephalitis:a case-control study.Lancet,2005,366:1375-1378.
[11] Wu Chang Jer, Li Tsung Lin,Huang Hui Wen,et al.Development of an effective Japanese encephalitis virus-specific DNA vaccine.Microbes Infection,2006,8:2578-2586.
[12] 黄莺,邵炜,贾丽丽,等.日本脑炎病毒(JEV)复制子表达载体的构建及其鉴定.病毒学报,2007,23(1):33-38. Huang Y, Shao W, Jia L L, et al.Construction and application of subgenomic replicon vectors of Japanese encephalitis virus.Chinese Journal of Virology, 2007,23(1):33-38.
[13] 汤德元,郭万柱.日本脑炎病毒及其疫苗的研究.中国兽医学报,2005,25:217-221. Tang D Y, Guo W Z. The development of Japanese encephalitis vaccine and vaccine research .Chinese Journal of Veterinary Science, 2005,25:217-221.
[14] Pugachev K V,Schwaiger J,Brown N,et al.Construction and biological characterization of artificial recombinants between a wild type flavivirus(Kunjin) and a live chimeric flavivirus vaccine(ChimeriVax-JE) .Vaccine,2007,25:666l-6671.
[15] Jones T.A chimeric live attenuated vaccine against Japanese encephalitis.Expert Rev Vaccines,2004,3:243-248.
[16] Chimeri Vax-JE Acambis plc. Acambis JE vaccine meets and exceeds primary endpoint in pivotal phase 3 efficacy trial.2007-03-01.
[17] Halstead S B, Thomas S J. New Japanese encephalitis vaccines: alternatives to production in mouse brain .Expert Rev Vaccine,2011,10(3):355-364.
[18] Wu S C, Yu C H, Lin C W, et al.The domain Ⅲ fragment of Japanese encephalitis virus envelope protein:mouse immunogenicity and liposome adjuvanticity.Vaccine, 2003,21(19/20):2516-2522.
[19] 杨杜鹃,李铭华,付士红,等.我国2009年新分离乙脑病毒全基因组序列特征研究.病毒学报,2011,27(6):571-579. Yang D J, Li M H, Fu S H, et al.Molecular characteristics of the full-length genomes of Japanese encephalitis virus strains newly isolated in 2009, China .Chinese Journal of Virology, 2011,27(6):571-579.
[20] 张括生,尚莉丽.近百年来流行性乙型脑炎流行病学特征及中医药防治乙脑策略进展.中医药临床杂志,2011,23(10):926-929. Zhang K S,Shang L L.Progress in epidemiological characteristics of epidemic encephalitis B and TCM prevention and treatment strategy of Japanese encephalitis in recent hundred years. Clinical Journal of Traditional Chinese Medicine, 2011,23(10):926-929.
[21] Fei-fei G,Jian W,Feng X,et al.Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine .Vaccine,2008,26(44):5590-5594.
[22] Dewasthaly S S, Bhonde G S,Shankarraman V,et al.Chimeric T helper-B cell peptides induce protective response against Japanese encephalitis virus in mice .Protein Pept Lett,2007,14(6):543-551.
[23] Wang L,Coppel R L.Oral vaccine delivery:can it protect against non-mucosal pathogens .Expert Rev Vaccines,2008,7(6):729-738.

[1] 陈鑫洁,钱芷兰,刘启,赵清,张元兴,蔡孟浩. 毕赤酵母底盘芳香族氨基酸合成途径改造生产肉桂酸及对香豆酸*[J]. 中国生物工程杂志, 2021, 41(10): 52-61.
[2] 王伟东,杜加茹,张运尚,樊剑鸣. CRISPR/Cas9在人病毒感染相关疾病治疗研究中的应用*[J]. 中国生物工程杂志, 2020, 40(12): 18-24.
[3] 徐应永. 基因治疗产品的开发现状与挑战[J]. 中国生物工程杂志, 2020, 40(12): 95-103.
[4] 王玥,牟彦双,刘忠华. 基于CRISPR/Cas系统的单碱基编辑技术研究进展*[J]. 中国生物工程杂志, 2020, 40(12): 58-66.
[5] 雷海英,赵青松,白凤麟,宋慧芳,王志军. 利用CRISPR/Cas9鉴定玉米发育相关基因ZmCen*[J]. 中国生物工程杂志, 2020, 40(12): 49-57.
[6] 何秀娟,胡凤枝,刘秋丽,刘玉萍,祝玲,郑文云. 乳腺癌细胞QSOX1的CRISPR/Cas9基因编辑及其对增殖侵袭的影响研究*[J]. 中国生物工程杂志, 2020, 40(11): 1-9.
[7] 张保惠,熊华龙,张天英,袁权. 基于水疱性口炎病毒(VSV)的溶瘤病毒研究进展 *[J]. 中国生物工程杂志, 2020, 40(6): 53-62.
[8] 刘迪,张洪春. 慢性阻塞性肺疾病基因工程动物模型研究进展 *[J]. 中国生物工程杂志, 2020, 40(4): 59-68.
[9] 菅璐,黄映辉,梁天亚,王利敏,马洪涛,张婷,李丹阳,王明连. 利用CRISPR/Cas9技术建立敲除JAK2基因K562细胞系 *[J]. 中国生物工程杂志, 2019, 39(7): 39-47.
[10] 郭超婧,朱琼,张新,李磊,张令强. 去泛素化酶OTUB1肝脏特异性基因敲除小鼠模型的构建与表型分析 *[J]. 中国生物工程杂志, 2019, 39(5): 80-87.
[11] 乔淼,胡杰,毛彬力,皮思蝶,胡源. 干扰素在肝癌细胞Huh7.0中诱导SAMHD1抑制HBV复制 *[J]. 中国生物工程杂志, 2019, 39(3): 1-6.
[12] 姚银,闵琪,熊海容,张莉. 木聚糖酶和甘露聚糖酶在毕赤酵母中的共表达及产酶分析 *[J]. 中国生物工程杂志, 2019, 39(3): 37-45.
[13] 田开仁,薛二淑,宋倩倩,乔建军,李艳妮. CRISPR-dCas9调控基因转录的研究进展 *[J]. 中国生物工程杂志, 2018, 38(7): 94-101.
[14] 庄旻敏,贾晓会,施定基,朱嘉诚,冯思豫,何培民,贾睿. 转基因聚球藻7942中vp28基因表达效率及其光合特性分析[J]. 中国生物工程杂志, 2018, 38(4): 30-37.
[15] 姚民,朱淑华,李佛生,张士彦,唐琳. 异源表达AtCYSa基因烟草的耐盐和抗虫特性分析[J]. 中国生物工程杂志, 2018, 38(4): 8-16.